Folate receptor-positive circulating tumor cells might function as potential biomarkers for hepatocellular carcinoma

doi:10.4251/wjgo.v17.i11.113431

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 11

This Article

(39)

(45)

(0)

(8)

(1)

(651)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Oncol. Nov 15, 2025; 17(11): 113431
Published online Nov 15, 2025. doi: 10.4251/wjgo.v17.i11.113431

Full Size Figure Download Figure

Figure 1 Comparative analysis of folate receptor-circulating tumor cell count and alpha fetoprotein for hepatocellular carcinoma diagnosis. A: Comparison of folate receptor-circulating tumor cell counts between patients with hepatocellular carcinoma and those with benign liver disease; B: Receiver operating characteristic curves of the folate receptor-circulating tumor cell count, the alpha fetoprotein level and the combination for hepatocellular carcinoma. CTC: Circulating tumor cell; HCC: Hepatocellular carcinoma; AUC: Area under the curve; AFP: Alpha fetoprotein.

Citation: Zhang ZY, Zhou M, Liu JJ, Zhang W. Folate receptor-positive circulating tumor cells might function as potential biomarkers for hepatocellular carcinoma. World J Gastrointest Oncol 2025; 17(11): 113431
URL: https://www.wjgnet.com/1948-5204/full/v17/i11/113431.htm
DOI: https://dx.doi.org/10.4251/wjgo.v17.i11.113431

Zhang ZY, Zhou M, Liu JJ, Zhang W. Folate receptor-positive circulating tumor cells might function as potential biomarkers for hepatocellular carcinoma. World J Gastrointest Oncol 2025; 17(11): 113431 [PMID: 41281492 DOI: 10.4251/wjgo.v17.i11.113431]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.